Dynamic measurement of airway surface liquid volume with an <i>ex vivo</i> trachea-chip.

Abstract

The volume and composition of airway surface liquid (ASL) is regulated by liquid secretion and absorption across airway epithelia, controlling the pH, solute concentration, and biophysical properties of ASL in health and disease. Here, we developed a method integrating explanted tracheal tissue with a micro-machined device (referred to as "<i>ex vivo</i> trachea-chip") to study the dynamic properties of ASL volume regulation. The <i>ex vivo</i> trachea-chip allows real-time measurement of ASL transport (<i>J</i>_v) with intact airway anatomic structures, environmental control, high-resolution, and enhanced experimental throughput. Applying this technology to freshly excised tissue we observed ASL absorption under basal conditions. The apical application of amiloride, an inhibitor of airway epithelial sodium channels (ENaC), reduced airway liquid absorption. Furthermore, the basolateral addition of NPPB, a Cl^- channel inhibitor, reduced the basal rate of ASL absorption, implicating a role for basolateral Cl^- channels in ASL volume regulation. When tissues were treated with apical amiloride and basolateral methacholine, a cholinergic agonist that stimulates secretion from airway submucosal glands, the net airway surface liquid production shifted from absorption to secretion. This <i>ex vivo</i> trachea-chip provides a new tool to investigate ASL transport dynamics in pulmonary disease states and may aid the development of new therapies targeting ASL regulation.